First Time Loading...

Zymeworks Inc
NYSE:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NYSE:ZYME
Watchlist
Price: 9.15 USD 1.67% Market Closed
Updated: May 16, 2024

Zymeworks Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zymeworks Inc
Operating Expenses Peer Comparison

Comparables:
TH
RPTX
FUSN
AUPH
EDT

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Zymeworks Inc
NYSE:ZYME
Operating Expenses
-$214.1m
CAGR 3-Years
2%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Operating Expenses
-$65.3m
CAGR 3-Years
-4%
CAGR 5-Years
-12%
CAGR 10-Years
-18%
Repare Therapeutics Inc
NASDAQ:RPTX
Operating Expenses
-$167.4m
CAGR 3-Years
-46%
CAGR 5-Years
-67%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Operating Expenses
-$101.3m
CAGR 3-Years
-39%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Operating Expenses
-$238.6m
CAGR 3-Years
-10%
CAGR 5-Years
-32%
CAGR 10-Years
-40%
Spectral Medical Inc
TSX:EDT
Operating Expenses
-CA$12.4m
CAGR 3-Years
-5%
CAGR 5-Years
-16%
CAGR 10-Years
1%

See Also

What is Zymeworks Inc's Operating Expenses?
Operating Expenses
-214.1m USD

Based on the financial report for Dec 31, 2023, Zymeworks Inc's Operating Expenses amounts to -214.1m USD.

What is Zymeworks Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-20%

Over the last year, the Operating Expenses growth was 24%. The average annual Operating Expenses growth rates for Zymeworks Inc have been 2% over the past three years , -20% over the past five years .